Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2010, Article ID 723782, 6 pages
http://dx.doi.org/10.4061/2010/723782
Review Article

Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease

Division of Molecular Psychiatry and Alzheimer Ph.D. Graduate School, Department of Psychiatry, University of Goettingen, von-Siebold-Str. 5, 37075 Goettingen, Germany

Received 3 May 2010; Revised 5 July 2010; Accepted 9 July 2010

Academic Editor: Gemma Casadesus

Copyright © 2010 Oliver Wirths and Thomas A. Bayer. This is an open access article distributed under the Creative Commons Attribution Licensee, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hardy and D. Allsop, “Amyloid deposition as the central event in the aetiology of Alzheimer's disease,” Trends in Pharmacological Sciences, vol. 12, no. 10, pp. 383–388, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Braak and E. Braak, “Neuropathological stageing of Alzheimer-related changes,” Acta Neuropathologica, vol. 82, no. 4, pp. 239–259, 1991. View at Google Scholar · View at Scopus
  3. G. K. Gouras, J. Tsai, J. Naslund et al., “Intraneuronal Aβ42 accumulation in human brain,” American Journal of Pathology, vol. 156, no. 1, pp. 15–20, 2000. View at Google Scholar · View at Scopus
  4. O. Wirths, G. Multhaup, and T. A. Bayer, “A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide–the first step of a fatal cascade,” Journal of Neurochemistry, vol. 91, no. 3, pp. 513–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Duyckaerts, M.-C. Potier, and B. Delatour, “Alzheimer disease models and human neuropathology: similarities and differences,” Acta Neuropathologica, vol. 115, no. 1, pp. 5–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Games, M. Buttini, D. Kobayashi, D. Schenk, and P. Seubert, “Mice as models: transgenic approaches and Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 9, supplement 3, pp. 133–149, 2006. View at Google Scholar · View at Scopus
  7. D. Games, D. Adams, R. Alessandrini et al., “Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein,” Nature, vol. 373, no. 6514, pp. 523–527, 1995. View at Google Scholar · View at Scopus
  8. K. K. Hsiao, P. Chapman, S. Nilsen et al., “Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice,” Science, vol. 274, no. 5284, pp. 99–102, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Moechars, I. Dewachter, K. Lorent et al., “Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain,” The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6483–6492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Chishti, D.-S. Yang, C. Janus et al., “Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695,” The Journal of Biological Chemistry, vol. 276, no. 24, pp. 21562–21570, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Sturchler-Pierrat, D. Abramowski, M. Duke et al., “Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 24, pp. 13287–13292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Lord, H. Kalimo, C. Eckman, X.-Q. Zhang, L. Lannfelt, and L. N. G. Nilsson, “The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice,” Neurobiology of Aging, vol. 27, no. 1, pp. 67–77, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Van Broeck, G. Vanhoutte, D. Pirici et al., “Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease,” Neurobiology of Aging, vol. 29, no. 2, pp. 241–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Tomiyama, S. Matsuyama, H. Iso et al., “A mouse model of amyloid ß oligomers: their contribution to synaptic alteration, abnormal Tau phosphorylation, glial activation, and neuronal loss in vivo,” Journal of Neuroscience, vol. 30, no. 14, pp. 4845–4856, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. R. Borchelt, T. Ratovitski, J. van Lare et al., “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron, vol. 19, no. 4, pp. 939–945, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Blanchard, S. Moussaoui, C. Czech et al., “Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice,” Experimental Neurology, vol. 184, no. 1, pp. 247–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. G. Richards, G. A. Higgins, A.-M. Ouagazzal et al., “PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation,” Journal of Neuroscience, vol. 23, no. 26, pp. 8989–9003, 2003. View at Google Scholar · View at Scopus
  18. C. Casas, N. Sergeant, J.-M. Itier et al., “Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model,” American Journal of Pathology, vol. 165, no. 4, pp. 1289–1300, 2004. View at Google Scholar · View at Scopus
  19. E. M. Ribé, M. Pérez, B. Puig et al., “Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice,” Neurobiology of Disease, vol. 20, no. 3, pp. 814–822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Oddo, A. Caccamo, J. D. Shepherd et al., “Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction,” Neuron, vol. 39, no. 3, pp. 409–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Grueninger, B. Bohrmann, C. Czech et al., “Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice,” Neurobiology of Disease, vol. 37, no. 2, pp. 294–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Irizarry, M. McNamara, K. Fedorchak, K. Hsiao, and B. T. Hyman, “APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1,” Journal of Neuropathology and Experimental Neurology, vol. 56, no. 9, pp. 965–973, 1997. View at Google Scholar · View at Scopus
  23. M. C. Irizarry, F. Soriano, M. McNamara et al., “Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse,” Journal of Neuroscience, vol. 17, no. 18, pp. 7053–7059, 1997. View at Google Scholar · View at Scopus
  24. F. M. LaFerla, B. T. Tinkle, C. J. Bieberich, C. C. Haudenschild, and G. Jay, “The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice,” Nature Genetics, vol. 9, no. 1, pp. 21–30, 1995. View at Google Scholar · View at Scopus
  25. M. E. Calhoun, K.-H. Wiederhold, D. Abramowski et al., “Neuron loss in APP transgenic mice,” Nature, vol. 395, no. 6704, pp. 755–756, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Urbanc, L. Cruz, R. Le et al., “Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 13990–13995, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Boncristiano, M. E. Calhoun, V. Howard et al., “Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice,” Neurobiology of Aging, vol. 26, no. 5, pp. 607–613, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Oakley, S. L. Cole, S. Logan et al., “Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation,” Journal of Neuroscience, vol. 26, no. 40, pp. 10129–10140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Schmitz, B. P. F. Rutten, A. Pielen et al., “Hippocampal neuron loss exceeds amyloid Plaque load in a transgenic mouse model of Alzheimer's disease,” American Journal of Pathology, vol. 164, no. 4, pp. 1495–1502, 2004. View at Google Scholar · View at Scopus
  30. B. P. F. Rutten, N. M. Van der Kolk, S. Schafer et al., “Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751 SL/PS1M146L transgenic mice,” American Journal of Pathology, vol. 167, no. 1, pp. 161–173, 2005. View at Google Scholar · View at Scopus
  31. H. Breyhan, O. Wirths, K. Duan, A. Marcello, J. Rettig, and T. A. Bayer, “APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy,” Acta Neuropathologica, vol. 117, no. 6, pp. 677–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Z. Christensen, S. L. Kraus, A. Flohr, M.-C. Cotel, O. Wirths, and T. A. Bayer, “Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice,” Acta Neuropathologica, vol. 116, no. 6, pp. 647–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Z. Christensen, T. A. Bayer, and O. Wirths, “Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease,” Neurobiology of Aging, vol. 31, no. 7, pp. 1153–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Takahashi, I. Brasnjevic, B. P. F. Rutten et al., “Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease,” Brain Structure and Function, vol. 214, no. 2-3, pp. 145–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. C. Cotel, S. Jawhar, D. Z. Christensen et al., “Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice,” Neurobiology of Aging. In press. View at Publisher · View at Google Scholar
  36. A. Faure, L. Verret, B. Bozon et al., “Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease,” Neurobiology of Aging. In press. View at Publisher · View at Google Scholar
  37. S. Jawhar, A. Trawicka, C. Jenneckens et al., “Motor deficits, neuron loss and reduced anxiety coinciding with axonal degeneration and intraneuronal Aß aggregation in the 5XFAD mouse model of Alzheimer's disease,” Neurobiology of Aging. In press. View at Publisher · View at Google Scholar
  38. T. C. Saido, T. Iwatsubo, D. M. A. Mann, H. Shimada, Y. Ihara, and S. Kawashima, “Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques,” Neuron, vol. 14, no. 2, pp. 457–466, 1995. View at Google Scholar · View at Scopus
  39. S. Schilling, T. Lauber, M. Schaupp et al., “On the seeding and oligomerization of pGlu-amyloid peptides (in vitro),” Biochemistry, vol. 45, no. 41, pp. 12393–12399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y.-M. Kuo, S. Webster, M. R. Emmerling, N. De Lima, and A. E. Roher, “Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβ peptides of Alzheimer's disease,” Biochimica et Biophysica Acta, vol. 1406, no. 3, pp. 291–298, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Russo, E. Violani, S. Salis et al., “Pyroglutamate-modified amyloid β-peptides—AβN3(pE)—strongly affect cultured neuron and astrocyte survival,” Journal of Neurochemistry, vol. 82, no. 6, pp. 1480–1489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Wirths, H. Breyhan, H. Cynis, S. Schilling, H.-U. Demuth, and T. A. Bayer, “Intraneuronal pyroglutamate-Aβ 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model,” Acta Neuropathologica, vol. 118, no. 4, pp. 487–496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Tomiyama, T. Nagata, H. Shimada et al., “A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia,” Annals of Neurology, vol. 63, no. 3, pp. 377–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. L. M. Billings, S. Oddo, K. N. Green, J. L. McGaugh, and F. M. LaFerla, “Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice,” Neuron, vol. 45, no. 5, pp. 675–688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Bertoni-Freddari, S. L. Sensi, B. Giorgetti et al., “Decreased presence of perforated synapses in a triple-transgenic mouse model of Alzheimer's disease,” Rejuvenation Research, vol. 11, no. 2, pp. 309–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Grueninger, B. Bohrmann, C. Czech et al., “Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice,” Neurobiology of Disease, vol. 37, no. 2, pp. 294–306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. E. D. Roberson, K. Scearce-Levie, J. J. Palop et al., “Reducing endogenous Tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model,” Science, vol. 316, no. 5825, pp. 750–754, 2007. View at Publisher · View at Google Scholar · View at Scopus